Cheap supplies of HIV-prevention jab for poorer countries hailed as ‘genuine chance to end’ global epidemic

Lenacapavir described as ‘next best thing’ to an HIV vaccine will cost $40 a year for each patient in 120 countries from 2027, funders say

Raccontata daaskanews.itcorriere.ittheguardian.combbc.comfortune.comindependent.co.uk